<DOC>
	<DOC>NCT01463007</DOC>
	<brief_summary>The purpose of this study is to evaluate the rate of early and intermediate toxicity related to the AccuBoost System for delivery of APBI in women with resected, early stage breast cancer.</brief_summary>
	<brief_title>Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1. A confirmed histological diagnosis of invasive breast carcinoma or DCIS 2. Age greater or equal to 50 years old 3. Life expectancy &gt; 6 months 4. Treated by breast conserving surgery with axillary node dissection or sentinel lymph node biopsy 5. Pathologic tumor size less than or equal to 2 cm 6. Invasive ductal, mucinous, tubular or colloid histology 7. Estrogen receptor positive for invasive carcinoma. 8. Unifocal/unicentric disease 9. Negative surgical margins greater than or equal to 2 mm 10. Pathologic lymph node negative 11. No evidence of lymphovascular invasion 12. ECOG performance status of 0 or 1 (Appendix 1) 13. Informed consent signed. 1. Known BRCA 1/2 Mutation; (BRCA 1 and 2 testing is not required) 2. Autoimmune disorder 3. Pregnancy 4. Breast implants 5. Psychiatric or addictive disorder that would preclude attending followup 6. Neoadjuvant chemotherapy (adjuvant chemotherapy is permitted) 7. Suspicious remaining microcalcification on postsurgery mammogram (unless biopsy proven benign) 8. Lobular features on histology (pure or mixed) or sarcoma histology 9. Node positive on axillary dissection or in the sentinel lymph node biopsy; 10. Extensive in situ carcinoma (EIC) 11. Multicentric or multifocal disease 12. Paget's disease of the nipple 13. Distant metastases 14. Lumpectomy cavity not well visualized on AccuBoost imaging 15. Lumpectomy cavity with 1cm margin (PTV) not adequately encompassed by any applicator (PTV &gt; 6cm) 16. Breast separation with compression &gt; 7cm. 17. Overlap of skin between orthogonal treatment axes.</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>invasive ductal cancer</keyword>
	<keyword>tubular breast cancer</keyword>
	<keyword>breast cancer</keyword>
	<keyword>colloid</keyword>
	<keyword>ER positive</keyword>
	<keyword>radiation</keyword>
</DOC>